MustGrow Biologics Appoints Kevin Helash as CEO
Bitget2026/11/02 12:05- MustGrow Biologics appointed Kevin Helash chief executive officer, effective November 1, 2026.
- Helash previously served as CEO of Biotalys, Marrone Bio Innovations and Agrinos, following senior executive roles at Agrium.
- Corey Giasson will transition to chief operating officer, focusing on internal operations, production and commercialization support.
- Colin Bletsky will become chief commercial officer, focusing on global product sales, market development and commercialization support.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
MinebeaMitsumi Shareholders to Sell 18,092,100 Shares in Secondary Offering
The U.S. Senate passes a landmark permitting reform bill to expedite grid and AI data center approvals
The U.S. Senate has passed a landmark bill that could comprehensively reform the country's energy permitting system.
Cracks in "AI trading" continue to appear, triggering a global stock sell-off, while US Treasuries are set for their longest rally in five months.
As concerns over artificial intelligence (AI) trading trends continue to deepen, the global stock market sell-off has intensified, leading investors to flock to safe-haven assets. As a result, US Treasuries are poised to experience their longest rally in nearly five months.